Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
Clinical trial NCT06819735 · RECRUITING
Trial details
- NCT number
- NCT06819735
- Sponsor
- Domain Therapeutics Australia Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-09-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.